Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + Cisplatin/Gemcitabine in Bladder Cancer
NCT01938573Phase 2Completed
- Sponsor
- University of Washington
- Start
- Oct 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in bladder cancer, sponsored by University of Washington. Started Oct 2013; status: completed.
02
Drugs
sirolimus
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01938573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938573.